This week I was wandering around the halls of the Consumer Electronics Show in Las Vegas and believe me the future of technology means that more of our patients will have less reason to get off the couch. There were great displays by software developers for activity related games such …

DAWN Reflection Sheet From the DAWN (Diabetes Attitudes Wishes & Needs) Program, the DAWN Reflection Sheet patient handout can help your patients set goals and make behavioral changes, easing their transitions in their way of life. DAWN Reflection Sheet

India Diabetes’ World Capital by 2025: Eminent heart surgeon V. V. Bashi said India would be the world capital of diabetes by 2025. “Diabetes is a big factor for heart disease. Eighty percent of those who suffer from diabetes in India invariably suffer from heart disease. In the western world, …

ADA Announces New Recommendations for the Diagnosis of Diabetes and Pre-Diabetes: The American Diabetes Association’s new Clinical Practice Recommendations, being published as a supplement to the January issue of Diabetes Care, call for the addition of the A1c test as a means of diagnosing diabetes and identifying pre-diabetes. The test has …

FDA Decision on Liraglutide Expected within Days: Danish pharma major Novo Nordisk said it expects formal feedback from the US Food and Drug Administration (FDA) regarding the new drug application (NDA) for its diabetes drug candidate liraglutide within days. Liraglutide is a once-daily human glucagon-like peptide-1 (GLP-1) analogue, which works by …

Faster, easier test could help reduce number of undiagnosed with diabetes and pre-diabetes.

Prehypertension is associated with cardiovascular disease and insulin resistance. However, whether subjects with prehypertension have more diabetes risk is not known. Researchers David R. Mullican, MD, Carlos Lorenzo, MD, and Steven M. Haffner, MD, University of Texas Health Science Center San Antonio, examined whether prehypertension is a risk factor for …

The purpose of the study is to summarize evidence about the diagnostic accuracy of the 5.07/10-g monofilament test in peripheral neuropathy.

A Blacksburg, VA, medical company says it is a step closer to finding a potential cure for Type 1 diabetes, tapping pigs as a source of healthy beta-cells. So far it has been successful in monkeys for more than a year. 

Biodel, Inc., announced that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject(R) as a treatment for diabetes.